Skip to content
Menu

Poniard Pharmaceuticals, Inc. PARD

Full chart Compare
Set alert

Price alert · PARD

All alert types
0.00 USD 0.00 (+0.00%)

Regular-session close

Day range unavailable

0.00001 52-week range 0.0001
YTD
0.00%
1 year
0.00%

Revenue & Expenses

Revenue Profit Costs
Other Income$330.00KGross Profit$15.00KNet Loss$21.00MExpenses$21.34MSelling, General & Admin$5.95MResearch & Development$10.20MOther Operating Expenses$4.93MInterest Expense$267.00KRevenue$15.00K

Latest period ending Dec 31, 2010 · select a line to chart its full history

PARD annual income statement
Fiscal yearFY 2010 Dec 31, 2010FY 2009 Dec 31, 2009FY 2008 Dec 31, 2008FY 2007 Dec 31, 2007FY 2006 Dec 31, 2006
-26.74M-42.98M-49.16M-35.35M-21.23M
-30.05M-45.72M-48.56M-32.78M-23.29M
-26.40-52.40-56.40-43.20-54.80
PARD annual balance sheet
Fiscal yearFY 2010 Dec 31, 2010FY 2009 Dec 31, 2009FY 2008 Dec 31, 2008FY 2007 Dec 31, 2007FY 2006 Dec 31, 2006
1.44M16.22M44.42M29.62M44.28M
11.64M52.44M84.23M105.14M69.07M
3.19M28.80M36.59M16.04M22.18M
1.57M20.27M25.36M10.81M13.88M
8.45M23.64M47.65M89.11M46.89M
PARD annual cash flow
Fiscal yearFY 2010 Dec 31, 2010FY 2009 Dec 31, 2009FY 2008 Dec 31, 2008FY 2007 Dec 31, 2007FY 2006 Dec 31, 2006
-24.28M-35.49M-33.49M-24.65M-17.27M
24.02M1.16M34.28M-55.54M-14.84M
-14.40M6.13M14.01M65.38M72.74M
51.00K91.00K-391.00K1.96M-275.00K
-14.65M-28.21M14.81M-14.81M40.63M